Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Automation
IT & Software
Return to: PBR Home | Automation | IT & Software | News
Search Refinements

IT & Software News

View news from other Pharmaceutical sectors:
1-15 of 1760 results
Numerate, Takeda partner to generate clinical candidates using AI-driven drug discovery
Numerate has entered into a multi-year agreement with Takeda Pharmaceutical under which it will identify and deliver multiple clinical candidates by applying artificial intelligence (AI) at cloud scale.
Automation > IT & Software > News
Novartis, IBM partner to optimize cancer care and improve patient outcomes
By PBR Staff Writer
Novartis has partnered with IBM Watson Health to explore the development of a cognitive solution, aimed at enhancing outcomes in advanced breast cancer.
Automation > IT & Software > News
Accenture, BioCelerate partner to advance biopharmaceutical innovation
Accenture and TransCelerate BioPharma's subsidiary BioCelerate have partnered to advance biopharmaceutical innovation through increased insights in research & development.
Automation > IT & Software > News
IBM scientists secure patent on machine learning models for drug discovery
By PBR Staff Writer
Technology giant IBM has secured a patent on machine learning models for drug discovery.
Automation > IT & Software > News
Veeva rolls out cloud application to accelerate regulatory submission delivery
Veeva Systems (VEEV) announced a new cloud application dubbed Veeva Vault Submissions Publishing that incorporates publishing capabilities within Veeva Vault RIM to accelerate regulatory submission delivery.
Automation > IT & Software > News
Arven selects GE Healthcare’s manufacturing platform to expand production capacity at Turkish facility
GE Healthcare’s FlexFactory manufacturing platform has been selected to expand production capacity at Arven Pharmaceuticals' facility in Kirklareli, Turkey.
Automation > IT & Software > News
IBM seeks public's help to find new cancer cures
Medical researchers and IBM are asking for the public's help in identifying prospective treatments for childhood cancers.
Automation > IT & Software > News
Lundbeck, IBM Watson Health partner for neurological and psychiatric drug discovery
H. Lundbeck is partnering with IBM's Watson Health to sped up the development of new medicines for the treatment of psychiatric and neurological disorders.
Automation > IT & Software > News
Abzena signs licensing deal for ThioBridge antibody drug conjugate linker technology
Abzena has entered into a licensing agreement with with a San Diego-based biopharmaceutical firm for its novel site-specific ThioBridge antibody drug conjugate (ADC) linker technology.
Automation > IT & Software > News
Pfizer, IBM partner to advance immuno-oncology research
By PBR Staff Writer
Pharmaceutical major Pfizer and technology giant IBM have partnered to accelerate immuno-oncology research.
Automation > IT & Software > News
Menarini-Silicon’s DEPArray technology aids researchers in lung cancer study
Menarini-Silicon Biosystems said its DEPArray single-cell isolation technology played an important role in a study carried out by researchers from The University of Manchester to develop a model for predicting whether small-cell lung cancer patients will be sensitive or resistant to initial chemo­therapy treatment.
Automation > IT & Software > News
Tillotts introduces new technology for colonic targeting of active molecules
Tillotts Pharma has introduced a new advanced enteric coating for solid dosage forms at this year's annual meeting of the American Association of Pharmaceutical Scientists.
Automation > IT & Software > News
PAREXEL launches IDMP-focused software solution for biopharmaceutical firms
PAREXEL International has launched an Identification of Medicinal Products (IDMP)-focused solution for biopharmaceutical companies.
Automation > IT & Software > News
IBM Watson, Broad Institute partner on $50m cancer drug resistance project
By PBR Staff Writer
IBM and the Broad Institute of MIT and Harvard have launched a five-year, $50m research initiative to study why cancers become drug resistant.
Automation > IT & Software > News
DNAtrix licenses Myxoma virus for new immunotherapy platform
DNAtrix, a privately held, clinical stage, biotechnology firm developing virus-driven immunotherapies for cancer, has entered into an exclusive license agreement with the University of Florida, Gainesville to develop a novel oncolytic virus platform.
Automation > IT & Software > News
1-15 of 1760 results